Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes

Area of Science:

• Platelet biology
• Molecular mechanisms of thrombosis
• MicroRNA regulation

Background:

• Platelets, though anucleate, contain mRNA and synthesize proteins, including microRNAs (miRNAs) and Dicer, crucial for miRNA maturation.
• Reduced Dicer and miRNA expression is observed in platelets of type 2 diabetes mellitus (T2DM) patients.
• The precise role of Dicer in platelet function and T2DM-associated hyperreactivity remains unclear.

Purpose of the Study:

• To investigate Dicer regulation in activated platelets.
• To determine if Dicer modulates mRNA translation via pre-microRNA maturation.
• To ascertain if these mechanisms are dysregulated in T2DM platelets.

Main Methods:

• Dicer expression analysis in human platelets using Western blotting, flow cytometry, and mass spectrometry.
• Quantification of microRNA-223 and P2RY12 transcripts via real-time PCR.
• In vivo studies using Dicer-deficient and diabetic mouse models.

Main Results:

• Activated platelets in healthy individuals rapidly synthesize Dicer, increasing microRNA-223 maturation and decreasing P2RY12 mRNA and P2Y12 expression/function.
• These regulatory mechanisms are significantly impaired in platelets from T2DM patients and in Dicer-deficient/diabetic mice.
• ADP-induced pulmonary thromboembolism was reduced in mice pre-treated with low-dose thrombin.

Conclusions:

• Dicer-mediated reduction of P2Y12 following thrombin stimulation may be a platelet self-regulation mechanism.
• Dysregulation of this pathway in T2DM contributes to platelet hyperreactivity and increased thrombotic risk.
• Impaired microRNA synthesis during platelet activation can promote cardiovascular disease.